Additionally, research on Ca9-22 oral cancer cells demonstrated that B7-H3 glycan contains terminal α-galactose and exhibits higher fucosylation and enhanced interactions with immune cells compared to B7-H3 from normal SG cells. Here, CD276 is linked to lip and oral cavity carcinoma.